Vorinostat (SAHA)

Catalog No. A10979

Vorinostat (SAHA)是HDAC的抑制剂,抑制脱乙酰和导致双方超乙酰化组蛋白和转录因子的积累。
  • Ting-Yu Chang, .et al. A novel histone deacetylase inhibitor MPT0L184 dysregulates cell-cycle checkpoints and initiates unscheduled mitotic signaling, Biomed Pharmacother, 2021, Jun;138:111485 PMID: 33740521
  • David Diaz-Carballo, .et al. Enhanced antitumoral activity of TLR7 agonists via activation of human endogenous retroviruses by HDAC inhibitors, Commun Biol, 2021, Mar 3;4(1):276 PMID: 33658617
  • Arshdeep Singh, .et al. CAP rigidification of MS-275 and chidamide leads to enhanced antiproliferative effects mediated through HDAC1, 2 and tubulin polymerization inhibition, Eur J Med Chem, 2021, Apr 5;215:113169 PMID: 33588178
  • Shariful Islam, .et al. Resistance to histone deacetylase inhibitors confers hypersensitivity to oncolytic reovirus therapy, Blood Adv, 2020, 4(20): 5297-5310 PMID: 33108458
  • Giovanni Bocci, .et al. Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19, ACS Pharmacol Transl Sci, 2020, Oct 14
Catalog Num A10979
M. Wt 264.3
Formula C14H20N2O3
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 149647-78-9
Synonyms Zolinza, MK-0683
SMILES C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO
Vorinostat (SAHA)是HDAC的抑制剂,抑制脱乙酰和导致双方超乙酰化组蛋白和转录因子的积累。
Targets
HDAC (Cell-free assay)
~10 nM
In vitro (25°C) DMSO 49 mg/mL (185.39 mM)
Water Insoluble
Ethanol 3 mg/mL (11.35 mM)
In vivo 2% DMSO+30% PEG 300+5% Tween 80+ddH2O 4 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 37.84 mL 189.18 mL 378.36 mL
0.5 mM 7.57 mL 37.84 mL 75.67 mL
1 mM 3.78 mL 18.92 mL 37.84 mL
5 mM 0.76 mL 3.78 mL 7.57 mL

*The above data is based on the productmolecular weight 264.3 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.